Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial.
Ann Oncol
; 29(2): 439-444, 2018 02 01.
Article
in En
| MEDLINE
| ID: mdl-29145602
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thymidylate Synthase
/
Colorectal Neoplasms
/
DNA-Binding Proteins
/
Endonucleases
/
Pharmacogenomic Testing
/
Pharmacogenomic Variants
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Oncol
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
España